Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Safety and Explore the Efficacy of J2H-1702 for Non-alcoholic Steatohepatitis

NCT06297434 is registered in ClinicalTrials.gov with J2H Biotech as lead sponsor.

NCT NCT06297434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06297434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IIa Clinical Trial to Evaluate the Safety and Explore the Efficacy of J2H-1702 for Non-alcoholic Steatohepatitis
Lead sponsor
J2H Biotech
Phase
Phase 2
Overall status
Completed
Start date
February 15, 2023
Completion date
November 5, 2025
Enrollment
87 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis